150
Participants
Start Date
December 8, 2023
Primary Completion Date
March 31, 2026
Study Completion Date
March 31, 2027
Axonics SNM System (Model 4101)
Safety and performance/effectiveness assessment of the recharge free Axonics SNM System (Model 4101 in participants with overactive bladder (OAB) or fecal incontinence (FI).
ACTIVE_NOT_RECRUITING
Columbia University Medical Center, New York
ACTIVE_NOT_RECRUITING
Southern Shores Urogynecology, Myrtle Beach
ACTIVE_NOT_RECRUITING
Atrium Health, Macon
ACTIVE_NOT_RECRUITING
East Coast Institute of Research, Jacksonville
ACTIVE_NOT_RECRUITING
Florida Bladder Institute, Naples
ACTIVE_NOT_RECRUITING
Florida Gulf Clinical Research, Bradenton
ACTIVE_NOT_RECRUITING
Minnesota Urology, Coon Rapids
ACTIVE_NOT_RECRUITING
Adult Pediatric Urology & Urogynecology, Omaha
ACTIVE_NOT_RECRUITING
Houston Colon, Houston
COMPLETED
The Oregon Clinic, Portland
ACTIVE_NOT_RECRUITING
Hartford Healthcare, Waterford
ACTIVE_NOT_RECRUITING
Erasmus Medical Center, Rotterdam
ACTIVE_NOT_RECRUITING
Queen Elizabeth Hospital, Birmingham
ACTIVE_NOT_RECRUITING
Bristol Urological Institute, Bristol
RECRUITING
University College London Hospital, London
ACTIVE_NOT_RECRUITING
Northern General Hospital, Sheffield
Lead Sponsor
Axonics, Inc.
INDUSTRY